Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Angela Hubanks

Physician Assistant, Medical Dubuque, IA Physician Assistant

NPI 1356538300 CMS profile 10746556

1515 Delhi St, Suite 100, Dubuque, IA 52001

Open in the dashboard

General payments

$2,164

129 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Angela Hubanks of Dubuque, IA is reported in the CMS Open Payments database as having received $2,164 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,116 68
2024 General $640 39
2023 General $254 12
2022 General $124 8
2021 General $31 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angela Hubanks
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Angela Hubanks were reported at $1,116. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Angela Hubanks Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $31 $156 $41–$563 $132
2022 $124 $185 $55–$649 $149
2023 $254 $199 $58–$717 $160
2024 $640 $206 $62–$740 $164
2025 $1,116 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $548 34 payments
  2. Novo Nordisk Inc $306 15 payments
  3. AstraZeneca Pharmaceuticals LP $271 10 payments
  4. Pfizer Inc. $212 24 payments
  5. Lilly USA, LLC $121 8 payments
  6. Astellas Pharma US Inc $102 5 payments
  7. Exact Sciences Corporation $92 5 payments
  8. Axsome Therapeutics, Inc. $77 1 payment
  9. Lundbeck LLC $53 3 payments
  10. Amgen Inc. $43 3 payments
  11. Other $338 21 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,132 128 payments
  2. Education $32 1 payment
Products named General payments · program years 2021–2025
  1. VRAYLAR Neuroscience $294 17 payments
  2. NURTEC ODT $212 24 payments
  3. ZAVZPRET $212 24 payments
  4. AIRSUPRA $194 5 payments
  5. Ozempic $157 12 payments
  6. Wegovy $150 3 payments
  7. VRAYLAR Neuroscience $138 9 payments
  8. BREZTRI $138 6 payments
  9. RYBELSUS $123 9 payments
  10. MOUNJARO $107 7 payments
  11. Other $1,128 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 94 drugs

Part D claims

3,839

Median for Physician Assistant: 241

Drug cost

$233,352

Median for Physician Assistant: $4,110

Branded share of claims

18.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 44 $39,981
Mounjaro Tirzepatide Brand 28 $39,524
Farxiga Dapagliflozin Propanediol Brand 38 $37,781
Xarelto Rivaroxaban Brand 15 $25,155
Eliquis Apixaban Brand 20 $15,099
Entresto Sacubitril/Valsartan Brand 13 $8,941
Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog Brand 18 $6,208
Breo Ellipta Fluticasone/Vilanterol Brand 13 $5,517
Ondansetron Hcl Generic 22 $5,298
Lantus Insulin Glargine,hum.Rec.Anlog Brand 15 $3,519

The 10 drugs with the highest cost, of 94 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 110 billing codes

Paid by Medicare

$57,949

Of which drugs: $7,869

Medicare patients

256

Average age 71

Services billed

2,087

184 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 58%
Diabetes 33%
Arthritis 32%
Depression 29%
Chronic kidney disease 23%
Atrial fibrillation 18%
Heart failure 17%
Ischemic heart disease 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 33 34 $2,772
Sarscv2 vac 30mcg trs-suc im 91320 Office 19 19 $2,678

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $102
$102 — —
Veozah
  • Astellas Pharma US Inc $79
$79 — —
BREZTRI
  • AstraZeneca Pharmaceuticals LP $62
$62 — —
GVOKE HYPOPEN
  • Xeris Pharmaceuticals, Inc. $41
$41 — —
Wegovy
  • Novo Nordisk Inc $32
$32 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record